Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation

Authors: Aviram M.; Rosenblat M.; Bisgaier C.L.; Newton R.S.

Source: Atherosclerosis, Volume 138, Number 2, June 1998 , pp. 271-280(10)

Publisher: Elsevier

Keywords: Lipid peroxidation; LDL; VLDL; HDL; Atorvastatin; Gemfibrozil; Paraoxonase

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0021-9150(98)00032-X

Affiliations: 1: The Lipid Research Laboratory, Technion Faculty of Medicine, The Rappaport Family Institute for Research in the Medical Sciences and Rambam Medical Center, Haifa 31096, Israel

Publication date: 1998-06-01

• In this: publication
• By this: publisher
• In this Subject: Cardiovascular Medicine
• By this author: Aviram M. ;  Rosenblat M. ;  Bisgaier C.L. ;  Newton R.S.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers